Law Daily Report

Weight loss drug contender Zealand Pharma jumps 23% on trial results

  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

News News

Law Law Latest News,Law Law Headlines

The Danish company is testing a rival to drugs such as Ozempic and Wegovy which it says may deliver a “better patient experience.”

Zealand Pharma shares popped on Friday on positive weight loss results from long-acting amylin analog petrelintide.

David Kendall, chief medical officer of Zealand Pharma, said that the petrelintide study supports the company's conviction that the drug"is very well tolerated and can potentially play an important role as an alternative to incretin-based therapies for the management of overweight and obesity."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 545. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Trump on trial in 60 seconds — day 23This is additional taxonomy that helps us with analytics
Source: MSNBC - 🏆 469. / 51 Read more »